Pharmaceutical Drug For Diabetes Causes Bladder Cancer
Another lawsuit has been filed against Takeda Pharmaceuticals alleging that the Type 2 Diabetes drug Actos caused a Florida man to develop bladder cancer. This is a case among thousands of others in the multidistrict litigation In Re: Actos (Pioglitazone) Products Liability Litigation (6:11-md-2299).
Actos is a drug that was prescribed to treat Type 2 diabetes. It has been found that the longer an individual took the drug, the greater their chances of developing bladder cancer. It is alleged that the Defendants of the lawsuit, Takeda Pharmaceuticals, were aware of the risk of developing bladder cancer but failed to inform consumers. It seems that the company was more concerned with their bottom line than the lives of the patients using the drug.
The U.S. Food and Drug Administration (FDA) released a statement in June 2011 that taking the drug for more than a year could significantly increase one’s risk of bladder cancer. This warning is unfortunately too late for many people that took the drug during years prior.
If you or your loved one took Actos to treat Type 2 diabetes and have now developed bladder cancer, call our Ohio product liability claims lawyers at 800.637.8170. Our legal team wants to help put an end to pharmaceutical companies taking advantage of patients so they can make a profit. We will fight to help you receive the compensation that you deserve for your pain and suffering.
